nonmetastatic gastric cancer. Malignant neoplasm of stomach
Conditions
Interventions
Intervention 1: Intervention group: Oral capecitabine (Rooyan daroo company, Rooyan AQVIDA line) at a dose of 1000 mg/m2 daily for two weeks in each three-week cycle (the patient does not take the dru
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who are adults and over 18 years of age Patients with non-metastatic gastric tumors Patients who received the FLOT regimen as neoadjuvant chemotherapy Patients who have undergone surgery and received chemotherapy after surgery
Exclusion criteria
Exclusion criteria: Patients with metastatic disease Patients who did not receive FLOT chemotherapy before surgery Patients who did not receive FLOT chemotherapy after surgery Non-metastatic patients who have not had surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor recurrence. Timepoint: At the beginning of the study (before the intervention), the end of the third month, the end of the sixth month, the end of the ninth month, and the end of the twelfth month after beginning chemotherapy. Method of measurement: CT scan of the chest, abdomen, and pelvis with and without contrast medium or ultrasound (if CT scan is not possible).;Drug side effects. Timepoint: At the beginning of the study (before the intervention), the end of the third month, the end of the sixth month, the end of the ninth month, and the end of the twelfth month after beginning chemotherapy. Method of measurement: Drug side effects questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Metastasis locations. Timepoint: At the beginning of the study (before the intervention), the end of the third month, the end of the sixth month, the end of the ninth month, and the end of the twelfth month after beginning chemotherapy. Method of measurement: CT scan of the chest, abdomen, and pelvis with and without contrast medium or ultrasound (if CT scan is not possible). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoghra Mohammadi
Shiraz University of Medical Sciences
Outcome results
None listed